Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenABCWY Vaccine in Healthy Adolescents
NCT02140762Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2014
- Primary completion
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Novartis. Started May 2014; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT02140762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140762.